Teikoku Pharma USA, Inc.

CA · United States · Reporting entity ID 100000276807

Total reported 2019–2025

$19.1M

#332 of 2,960 reporting companies — 0% of all reported industry payments

$222K in general payments across 17 records, plus $18.9M in research funding across 5 records.

How it breaks down

General payments $221,587

Research funding $18,901,707

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.